Alicia is an expert in commercial patient HUB operations and new product launches with over 10 years of global experience in creating, developing, and managing patient assistance programs in multiple therapeutic areas.

Prior to coming to COPILOT, Alicia’s most recent experience includes her expertise in the cell and gene space. While at Kite, A Gilead Company, Alicia was a key player for the development of the end-to-end process, patient enrollment to product delivery, of getting the first approved CAR-T therapy for adults to transplant centers both in the US and ex-US. At Gamida Cell, Alicia was responsible for creating and overseeing end-to-end patient journey, with supporting operational efficiencies, leading the project management of system and process validations in preparation of FDA submission.

Alicia is committed to continuing her journey in improving operational efficiency in patient services and creating unique developments to ensure speed to therapy for patient access. She is a patient advocate in her community, with the goal of decreasing the gap in the health disparities.

Alicia completed her Bachelor of Science (B.S.) degree in Health Education from The University of Central Arkansas. Following that, she pursued and obtained her Master of Science (M.S.) degree in Health Administration/Education from the same institution, The University of Central Arkansas. These educational achievements have equipped her with a strong foundation and expertise in the field of health education and administration.